We are on Bluesky now! Come find us → @icmlugano.bsky.social.

⏳ Last week for 18-ICML abstract submission! (deadline 15 March at 17:59 CET). 📊 Late-breaking abstracts: covering letters due by 15 March at 17:59 CET. 👉 #lymphoma #lymsm #CLL #myeloma

⏰Only one week left to take advantage of the #18ICML early registration fee! (deadline: 28 February 2025). 🔗Register here: #lymphoma #lymsm #CLL #myeloma

⌛ Only one month left to take advantage of the #18ICML early registration fee (February 28)!. More information: #lymphoma #lymsm #CLL #myeloma

📢 📄 The abstract submission for the #18ICML is officially OPEN! Abstracts can be related to all aspects of the biology and treatment of #lymphoidneoplasms, including #CLL and #multiplemyeloma. More info: #lymsm #lymphoma #myeloma

📢Registration for the 2025 Lymphoma Forum of Excellence is open! .Join this annual meeting in Bellinzona, Switzerland. Designed by lymphoma experts, the program offers updated knowledge and multidisciplinary case discussions. 🔗Info and registration:

📢Registration to the 18-ICML is open!.Don't miss the opportunity to participate in the only international conference that focuses exclusively on #lymphoidneoplasms!. 🔗Register now:

RT @AACR: Deadline Extended:.Submit an abstract by April 19 for the Fourth AACR International Meeting on Advances in Malignant Lymphoma (Ju….

RT @IOR_Bellinzona: #IORnews.We are honored to announce that the IOR Foundation President, Prof. Franco Cavalli, will receive the "Award fo….

RT @IOR_Bellinzona: #IORnews.The Lymphoma Genomics Lab, guided by Prof. Bertoni @frbertoni identified a new mechanism behind the resistance….

Thank you for attending the #17ICML!. A huge "thank you" also to our Advisory Board, Reviewers, Faculty, cooperating Scientific Societies @AACR @ESOncology @myESMO and Sponsors for their precious support. See you in 2025!

RT @IOR_Bellinzona: 🔍💼 CALL FOR NEW GROUP LEADER AT THE IOR. The IOR is looking for a Group Leader in Lymphoma Biology and Therapy. More i….

RT @frbertoni: formal ⁦@icmlugano⁩ #icml17 opening!

See you tomorrow at the #17ICML !

📖 The #17ICML Abstract and Educational Books, supplements to "Hematological Oncology" (John Wiley and Sons, Inc.), are online!. 🔗 Abstract Book: 🔗 Educational Book:

🎤#17-ICML Late Breaking Abstracts Session.The content of the #17ICML Late Breaking Abstracts Session (Saturday, June 17, 10:15 - 11:30) is now online!. 👉🏻 Discover the presentations here: 

🏃🏻Join the «Corsa della speranza (Run for Hope)», a charity run organized in collaboration with «La Corsa della speranza» during the 17-ICML with the aim to collect funds for cancer research projects carried out in Southern Switzerland. 🔗

Lugano is getting ready for #17ICML💪!

🎤#17ICML Plenary session."Nivolumab(N)-AVD Improves Progression-Free Survival Compared to Brentuximab Vedotin(BV)-AVD in Advanced Stage (AS) Classic Hodgkin Lymphoma (HL): Results of SWOG S1826" A. F. Herrera (Duarte, CA, US.🔗Complete Scientific Program:

🎤#17ICML Plenary session."Frontline intensified ABVD demonstrates superior efficacy than PET-adapted ABVD in advanced HL: the FIL-Rouge Phase 3 Trial by the Fondazione Italiana Linfomi" A. Pinto (Naples, IT). 👉🏻Check out the complete Scientific Program: